Advanced search
Publication Cover
Journal of Medical Economics Volume 26, 2023 - Issue 1
Submit an article Journal homepage
636
Views
0
CrossRef citations to date
0
Altmetric
Cardiovascular

Cost-effectiveness of Left Atrial Appendage Closure with WATCHMAN device for non-valvular atrial fibrillation patients in Japan. Are the policy implications big in Japan?

Panagiotis PetrouDepartment of Health Sciences, School of Pharmacy, Pharmacoepidemiology- Pharmacovigilance, University of Nicosia, Nicosia, CyprusCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-4881-720XView further author information
ORCID Icon
Pages 1301-1302 | Received 20 Aug 2023, Accepted 18 Sep 2023, Published online: 20 Oct 2023

References

  • Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomized non-inferiority trial. Lancet. 2009;374:534–542.
  • Reddy VY, Holmes D, Doshi SK, et al. Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry. Circulation. 2011;123(4):417–424. doi: 10.1161/CIRCULATIONAHA.110.976449.
  • Reddy VY, Doshi SK, Kar S, et al. 5-year outcomes after left atrial appendage closure: from the PREVAIL and PROTECT AF trials. J Am Coll Cardiol. 2017;70(24):2964–2975. doi: 10.1016/j.jacc.2017.10.021.
  • Holmes DR Jr, Kar S, Price MJ, et al. Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. J Am Coll Cardiol. 2014;64(1):1–12. doi: 10.1016/j.jacc.2014.04.029.
  • Kamae I, Zhong Y, Hara H, et al. Cost-effectiveness of left atrial appendage closure with WATCHMAN for non-valvular atrial fibrillation patients in Japan. J Med Econ. Submitted
  • Aonuma K, Yamasaki H, Nakamura M, et al. Percutaneous WATCHMAN left atrial appendage closure for japanese patients with nonvalvular atrial fibrillation at increased risk of thromboembolism – first results from the SALUTE trial. Circ J. 2018;82(12):2946–2953. Page 17 of 36 doi: 10.1253/circj.CJ-18-0222.
  • Naganuma M, Shiga T, Sato K, et al. Clinical outcome in Japanese elderly patients with non-valvular atrial fibrillation taking warfarin: a single-center observational study. Thromb Res. 2012;130(1):21–26. doi: 10.1016/j.thromres.2011.11.005.
  • Lee VW, Tsai RB, Chow IH, et al. Cost-effectiveness analysis of left atrial appendage occlusion compared with pharmacological strategies for stroke prevention in atrial fibrillation. BMC Cardiovasc Disord. 2016;16(1):167. PMID: 27581874; PMCID: PMC5007846 doi: 10.1186/s12872-016-0351-y.
  • Kreidieh B, Mañero MR, Cortez SH, et al. The cost effectiveness of LAA exclusion. J Atr Fibrillation. 2016;8(5):1374. PMID: 27909482; PMCID: PMC5089495. doi: 10.4022/jafib.1374.
  • Glikson M, Wolff R, Hindricks G, et al. EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion - an update. Europace. 2020;22(2):184–184. Epub 2019 Aug 31. PMID: 31504441. doi: 10.1093/europace/euz258.
  • Kipp R, Lehman J, Israel J, et al. Patient preferences for coronary artery bypass graft surgery or percutaneous intervention in multivessel coronary artery disease. Catheter Cardiovasc Interv. 2013;82(2):212–218. Epub 2013 May 6. PMID: 22517566; PMCID: PMC4180283. doi: 10.1002/ccd.24399.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.